These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 36934033
1. A novel endoscopic approach for management of hutch diverticulum concomitant vesicoureteral reflux with dextranomer/hyaluronic acid copolymer injection. Pourabhari Langroudi A, Shokri Varniab Z, Nabavizadeh B, Neishabouri A, Kajbafzadeh AM. J Pediatr Urol; 2023 Jun; 19(3):321.e1-321.e7. PubMed ID: 36934033 [Abstract] [Full Text] [Related]
2. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S. J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [Abstract] [Full Text] [Related]
10. High-grade vesicoureteral reflux in infants: Our experience with endoscopic subureteric injections. Al Hindi S, Mubarak M, Al Aradi H. Urologia; 2022 Feb; 89(1):120-125. PubMed ID: 33063631 [Abstract] [Full Text] [Related]
11. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. Kirsch AJ, Perez-Brayfield MR, Scherz HC. J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692 [Abstract] [Full Text] [Related]
12. Interventions for primary vesicoureteric reflux. Williams G, Hodson EM, Craig JC. Cochrane Database Syst Rev; 2019 Feb 20; 2(2):CD001532. PubMed ID: 30784039 [Abstract] [Full Text] [Related]
17. Efficacy of Bladder Ultrasound in Prediction of Resolution of Vesicoureteral Reflux After Endoscopic Subureteral Hyaluronic Acid/Dextranomer (Deflux) Injection. Aboutaleb H, Eldib DB, Farahat Y, Abouelgreed TA, Zanaty F. Urology; 2022 Jul 20; 165():299-304. PubMed ID: 35065987 [Abstract] [Full Text] [Related]
18. [Long-term results after endoscopic subureteral injection for VUR using dextranomer/hyaluronic acid copolymer : a five years experience]. Seibold J, Werther M, Sievert KD, Stenzl A. Urologe A; 2010 Apr 20; 49(4):536-9. PubMed ID: 20063087 [Abstract] [Full Text] [Related]
19. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children. Kocaoglu C. J Pediatr Surg; 2016 Oct 20; 51(10):1711-5. PubMed ID: 27117052 [Abstract] [Full Text] [Related]
20. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR). García-Aparicio L, Blázquez-Gómez E, Martin O, Pérez-Bertólez S, Arboleda J, Soria A, Tarrado X. World J Urol; 2018 Oct 20; 36(10):1651-1656. PubMed ID: 29725806 [Abstract] [Full Text] [Related] Page: [Next] [New Search]